Please login to the form below

Not currently logged in
Email:
Password:

Key considerations for disease- modifying Parkinson’s disease trials

‘Lessons learnt from Alzheimer’s trials could help in Parkinson’s drug development’

Shoring up the framework

buildingsEuropean regulators add a measure of clarity to pharma’s uncertainty around Brexit

Japanese pharma pulls no punches with post-Brexit UK

Japan_BrexitFirm want reassurance from the UK on its future in science and innovation

Brexit: the facts (and the alternative facts)

How Brexit affects pharma

Brexit: Implications for the pharma industry

Brexit_glovesFrom patents to the EMA, data protection to clinical trials, there's a lot that should be a concern

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics